57
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLECellular and Molecular Biology

Prostate Tumor-Inducing Gene-1 Analysis in Human Prostate Cancer Cells and Tissue in Relation to Mycoplasma Infection

, , , , , , , & show all
Pages 800-808 | Published online: 11 Jun 2009

REFERENCES

  • Lund A., Knudsen S.M., Vissing H., Clark B., Tommerup N. Assignment of human elongation factor 1alpha genes: EEF1A maps to chromosome 6q14 and EEF1A2 to 20q13.3. Genomics 1996; 36: 359–361
  • Shen R., Su Z.Z., Olsson C.A., Fisher P.B. Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display. Proc Natl Acad Sci USA 1995; 92: 6778–6782
  • Mansilla F., Hansen L.L., Jakobsen H., Kjeldgaard N.O., Clark B.F., Knudsen C.R. Deconstructing PTI-1: PTI-1 is a truncated, but not mutated, form of translation elongatin factor 1A1, eEF1A1. Biochim Biophys Acta 2005; 1727: 116–124
  • Sun Y., Lin J., Katz A.E., Fisher P.B. Human prostatic carcinoma oncogene PTI-1 is expressed in human tumor cell lines and prostate carcinoma patient blood samples. Cancer Res 1997; 57: 18–23
  • Su Z., Goldstein N.I., Fisher P.B. Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes. Proc Natl Acad Sci USA 1998; 95: 1764–1769
  • Gopalkrishnan R.V., Su Z.Z., Goldstein N.I., Fisher P.B. Translational infidelity and human cancer: role of the PTI-1 oncogene. Int J Biochem Cell Biol 1999; 31: 151–162
  • Su Z., Goldstein N.I., Fisher P.B. Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes. Proc Natl Acad Sci USA 1998; 95: 1764–1769
  • Mycoplasma detection by PCR analysis. In vitro Cellular and Development. 1993; 819–821
  • Stanta G., Mucelli S.P., Petrera F., Bonin S., Bussolati G. A novel fixative improves opportunities of nucleic acids and proteomic analysis in human archive's tissues. Diagn Mol Pathol 2006; 15: 115–123
  • Bonin S., Pascolo L., Croce L.S., Stanta G., Tiribelli C. Gene expression of ABC proteins in hepatocellular carcinoma, perineoplastic tissue, and liver diseases. Mol Med 2002; 8: 318–325
  • Stanta G., Schneider C. RNA extracted from paraffin-embedded human tissues is amenable to analysis by PCR amplification. Biotechniques 1991; 11, 304, 306, 308
  • Stanta G., Bonin S., Losi L., Eusebi V. Molecular characterization of intraductal breast carcinomas. Virchows Arch 1998; 432: 107–111
  • Stanta G., Bonin S. RNA quantitative analysis from fixed and paraffin-embedded tissues: membrane hybridization and capillary electrophoresis. Biotechniques 1998; 24: 271–276
  • Dapas B., Tell G., Scaloni A., Pines A., Ferrara L., Quadrifoglio F., Scaggiante B. Identification of different isoforms of eEF1A in the nuclear fraction of human T-lymphoblastic cancer cell line specifically binding to aptameric cytotoxic GT oligomers. Eur J Biochem 2003; 270: 3251–3262
  • Bertram J., Palfner K., Hiddemann W., Kneba M. Overexpression of ribosomal proteins L4 and L5 and the putative alternative elongation factor PTI-1 in the doxorubicin resistant human colon cancer cell line LoVoDxR. Eur J Cancer 1998; 34: 731–736
  • Beyer-Sehlmeyer G., Hiddemann W., Wormann B., Bertram J. Suppressive subtractive hybridisation reveals differential expression of serglycin, sorcin, bone marrow proteoglycan and prostate-tumour-inducing gene I (PTI-1) in drug-resistant and sensitive tumour cell lines of haematopoetic origin. Eur J Cancer 1999; 35: 1735–1742
  • Jacobs J. P., Jones C.M., Baille J.P. Characteristics of a human diploid cell designated MRC-5. Nature 1970; 227: 168–170
  • van Steenbrugge G.J., Groen M., van Dongen J.W., Bolt J., van der K.H., Trapman J., Hasenson M., Horoszewicz J. The human prostatic carcinoma cell line LNCaP and its derivatives. An overview. Urol Res 1989; 17: 71–77
  • Tilley W.D., Wilson C.M., Marcelli M., McPhaul M.J. Androgen receptor gene expression in human prostate carcinoma cell lines. Cancer Res 1990; 50: 5382–5386
  • Timenetsky J., Santos L.M., Buzinhani M., Mettifogo E. Detection of multiple mycoplasma infection in cell cultures by PCR. Braz J Med Biol Res 2006; 39: 907–914
  • Shen R., Su Z.Z., Olsson C.A., Fisher P.B. Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display. Proc Natl Acad Sci USA 1995; 92: 6778–6782
  • Shen R., Su Z.Z., Olsson C.A., Fisher P.B. Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display. Proc Natl Acad Sci USA 1995; 92: 6778–6782
  • Ohnami S., Matsumoto N., Nakano M., Aoki K., Nagasaki K., Sugimura T., Terada M., Yoshida T. Identification of genes showing differential expression in antisense K-ras-transduced pancreatic cancer cells with suppressed tumorigenicity. Cancer Res 1999; 59: 5565–5571
  • Ketcham C.M., Anai S., Reutzel R., Sheng S., Schuster S.M., Brenes R.B., Agbandje-McKenna M., McKenna R., Rosser C.J., Boehlein S.K. p37 Induces tumor invasiveness. Mol Cancer Ther 2005; 4: 1031–1038

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.